Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name BGT226
Trade Name
Synonyms NVP-BGT226
Drug Descriptions

BGT226 is a dual inhibitor of class I PI3K kinases and mTOR, which may inhibit tumor celll proliferation and tumor growth (PMID: 21976531, PMID: 31190275).

DrugClasses mTOR Inhibitor 51 PI3K Inhibitor (Pan) 42
CAS Registry Number 1245537-68-1
NCIT ID C74073

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BGT226 BGT226 1 0
BGT226 + Imatinib BGT226 Imatinib 0 0
BGT226 + Nilotinib BGT226 Nilotinib 0 0
BGT226 + Olverembatinib BGT226 Olverembatinib 0 0


Additional content available in CKB BOOST